[mo_oauth_login]
Summary report
TBD PHARMATECH OÜ
Date of report 06.05.2025
TBD PHARMATECH OÜ
11204964 -
Registered
Founded in
10.02.2006
Fixed capital
7,136 €
Former names
- osaühing TBD-Biodiscovery
VAT
EE101057350
(start 13.06.2006)
| start | end |
|---|---|
| 13.06.2006 | - |
keywords
- laboratooriumid
- riik ja ühiskond
- teadusasutused
- põhifarmaatsiatoodete tootmine
TBD PHARMATECH OÜ
Scores and ratings
Reputation score
7190
What is Reputation score?
Credit Score
Trustworthy
0.01
Credit score today
Trustworthy
0.01
2020
year
Open the reports you want to print
Employees and salaries
TBD PHARMATECH OÜ
Number of employees and estimated average salaries?
| 2024 II | 2024 III | 2024 IV | 2025 I | |
| Number of employees | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
TBD PHARMATECH OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2025 I | ...... | ...... | ...... | ...... |
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
| 2019 IV | ...... | ...... | ...... | ...... |
| 2019 III | ...... | ...... | ...... | ...... |
| 2019 II | ...... | ...... | ...... | ...... |
| 2019 I | ...... | ...... | ...... | ...... |
| 2018 IV | ...... | ...... | ...... | ...... |
| 2018 III | ...... | ...... | ...... | ...... |
| 2018 II | ...... | ...... | ...... | ...... |
| 2018 I | ...... | ...... | ...... | ...... |
| 2017 IV | ...... | ...... | ...... | ...... |
| 2017 III | ...... | ...... | ...... | ...... |
| 2017 II | ...... | ...... | ...... | ...... |
| 2017 I | ...... | ...... | ...... | ...... |
| 2016 IV | ...... | ...... | ...... | ...... |
| 2016 III | ...... | ...... | ...... | ...... |
| 2016 II | ...... | ...... | ...... | ...... |
| 2016 I | ...... | ...... | ...... | ...... |
| 2015 IV | ...... | ...... | ...... | ...... |
| 2015 III | ...... | ...... | ...... | ...... |
| 2015 II | ...... | ...... | ...... | ...... |
| 2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
TBD PHARMATECH OÜ
Decision-makers?
Former decision-makers
Relations:
6
Turnover 2025:
9 225 370 €
Employees:
62
Andrus Tasa
★★★★
......
Credit Score: Trustworthy
Reputation score: 13930
Date of birth: ......
Active relations 6
13 followers
Relations:
3
Turnover 2025:
7 481 417 €
Employees:
59
Tõnis Tasa
★★★★
......
Credit Score: Trustworthy
Reputation score: 7590
Date of birth: ......
Active relations 3
2 followers
*Every member of the management board may represent the private limited company in concluding all transactions.
TBD PHARMATECH OÜ
Former decision-makers?
Relations:
2
Turnover 2025:
12 174 €
Employees:
1
Allan Nurk
★★★★
......
Credit Score: Trustworthy
Reputation score: 790
Date of birth: ......
Active relations 2
7 followers
Relations:
6
Turnover 2025:
9 225 370 €
Employees:
62
Andrus Tasa
★★★★
......
Credit Score: Trustworthy
Reputation score: 13930
Date of birth: ......
Active relations 6
13 followers
Relations:
1
Turnover 2025:
193 €
Employees:
Ago Rinken
★★★★
......
Credit Score: Trustworthy
Reputation score: 930
Date of birth: ......
Active relations 1
6 followers
Relations:
1
Turnover:
Employees:
Uno Mäeorg
★★★★
......
Credit Score: Trustworthy
Reputation score: 730
Date of birth: ......
Active relations 1
4 followers
Relations:
4
Turnover 2025:
2 940 471 €
Employees:
8
Jaanus Vahtra
★★★★
......
Credit Score: Neutral
Reputation score: 9710
Date of birth: ......
Active relations 4
45 followers
Relations:
1
Turnover 2025:
1 796 €
Employees:
Olga Tšubrik
★★★★
......
Credit Score: Trustworthy
Reputation score: 330
Date of birth: ......
Active relations 1
9 followers
TBD PHARMATECH OÜ
History of right of representation?
Field
Manufactoring
Business age
19y
Beneficial country:
Estonia
Tõnis Tasa
... - ...
Andrus Tasa
... - ...
Olga Tšubrik
... - ...
Jaanus Vahtra
... - ...
Uno Mäeorg
... - ...
Andrus Tasa
... - ...
Ago Rinken
... - ...
Allan Nurk
... - ...
2006
2009
2011
2014
2017
2020
2022
2025
2006
2008
2009
2011
2013
2015
2016
2018
2020
2022
2023
2025
TBD PHARMATECH OÜ
Owners?
Former owners
Former owners
| Name | Credit Score | Payment | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... |
TBD PHARMATECH OÜ
Other related parties?
Former other persons
Other related parties (invalid relations)
| Name | Credit Score | Part | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... |
Beneficiaries
Volumes and values of beneficiaries' assets
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Finances and assets
TBD PHARMATECH OÜ
Goodwill| EUR | 2023 | 2024 | 2025 | Trend |
| Goodwill | ...... | ...... | ...... | |
| Goodwill | ...... | ...... | ...... |
TBD PHARMATECH OÜ
Taxes paid and estimated average salaries| 2022 | 2023 | 2024 | 2025 | |
| National taxes | ...... | ...... | ...... | ...... |
| Labor taxes | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
TBD PHARMATECH OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2025 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
TBD PHARMATECH OÜ
Sales revenue by business arearevenue
| Field of activity | EMTAK code | Sales revenue (2023) | Sales revenue % |
| Manufacture of pharmaceutical products | 21101 | 4 113 616 € | 99,95 |
| Purchase of waste (warehouse and packaging) | - | - | |
| Wholesale of solid fuel | 46711 | 2124 € | 0,05 |
TBD PHARMATECH OÜ
Sales revenue by country| Turnover EUR | 2023 | 2024 prognosis | 2025 prognosis | Trend |
| Total sales | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Ascension Island | ...... | ...... | ...... | |
| Austria | ...... | ...... | ...... | |
| Bangladesh | ...... | ...... | ...... | |
| Denmark | ...... | ...... | ...... | |
| Finland | ...... | ...... | ...... | |
| France | ...... | ...... | ...... | |
| Germany | ...... | ...... | ...... | |
| India | ...... | ...... | ...... | |
| Israel | ...... | ...... | ...... | |
| Italy | ...... | ...... | ...... | |
| Japan | ...... | ...... | ...... | |
| Korea, Republic of | ...... | ...... | ...... | |
| Latvia | ...... | ...... | ...... | |
| Netherlands | ...... | ...... | ...... | |
| Netherlands Antilles | ...... | ...... | ...... | |
| Poland | ...... | ...... | ...... | |
| Russian Federation | ...... | ...... | ...... | |
| Spain | ...... | ...... | ...... | |
| Sweden | ...... | ...... | ...... | |
| Switzerland | ...... | ...... | ...... | |
| United Kingdom of Great Britain and Northern Ireland | ...... | ...... | ...... | |
| United States of America | ...... | ...... | ...... | |
| Total exports | ...... | ...... | ...... |
TBD PHARMATECH OÜ
Financial indicators and prognosis| Financial indicators | 2023 | 2024 Prognosis | 2025 Prognosis |
Trend |
| TURNOVER | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Other countries | ...... | ...... | ...... | |
| INTEREST INCOME | ...... | ...... | ...... | |
| OTHER BUSINESS INCOME | ...... | ...... | ...... | |
| TURNOVER IN RELATED COMPANY | ...... | ...... | ...... | |
| AVERAGE MONTHLY TURNOVER | ...... | ...... | ...... | |
| Available credit (credit limit) | ...... | ...... | ...... | |
| Settlement dates | ...... | ...... | ...... | |
| RECEIVED GRANTS € | ...... | ...... | ...... | |
| TENDERS WON € | ...... | ...... | ...... | |
| ASSETS | ...... | ...... | ...... | |
| Current assets | ...... | ...... | ...... | |
| Fixed assets | ...... | ...... | ...... | |
| LIABILITIES | ...... | ...... | ...... | |
| Short-term liabilities | ...... | ...... | ...... | |
| Long-term liabilities | ...... | ...... | ...... | |
| EQUITY | ...... | ...... | ...... | |
| Share-(equity capital) | ...... | ...... | ...... | |
| Retained profits | ...... | ...... | ...... | |
| Net profit | ...... | ...... | ...... | |
| NET WORKING CAPITAL | ...... | ...... | ...... | |
| NUMBER OF EMPLOYEES | ...... | ...... | ...... |
TBD PHARMATECH OÜ
Financial raiting: "GOOD" (2025 prognosis)| Multipliers and income levels | 2024 prognosis | 2025 prognosis |
Trend |
| LIQUIDITY | ...... | ...... | |
| Net Working capital | ...... | ...... | |
| Short-term debt coverage ratio (X) | ...... | ...... | |
| EFFECTIVENESS | ...... | ...... | |
| Debt to assets ratio (X) | ...... | ...... | |
| Capitalisation multiplier (X) | ...... | ...... | |
| USE OF LOAN CAPITAL | ...... | ...... | |
| Turnover ratio of fixed assets (X) | ...... | ...... | |
| PROFITABILITY | ...... | ...... | |
| Sales revenues (%) | ...... | ...... | |
| Total asset revenues (%) | ...... | ...... | |
| Equity revenues (%) | ...... | ...... |
2025 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
TBD PHARMATECH OÜ
Real estate as of 06.05.2025Active and unactive real estate
V......
V......
V......
V......
V......
V......
TBD PHARMATECH OÜ
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2023 | 01.01.2023–31.12.2023 | 25.06.2024 | ...... |
| 2022 | 01.01.2022–31.12.2022 | 27.06.2023 | ...... |
| 2021 | 01.01.2021–31.12.2021 | 24.05.2022 | ...... |
| 2020 | 01.01.2020–31.12.2020 | 24.05.2021 | ...... |
| 2019 | 01.01.2019–31.12.2019 | 20.05.2020 | ...... |
| 2018 | 01.01.2018–31.12.2018 | 17.04.2019 | ...... |
| 2017 | 01.01.2017–31.12.2017 | 31.05.2018 | ...... |
| 2016 | 01.01.2016–31.12.2016 | 14.06.2017 | ...... |
| 2015 | 01.01.2015–31.12.2015 | 31.05.2016 | ...... |
| 2014 | 01.01.2014–31.12.2014 | 26.06.2015 | ...... |
| 2013 | 01.01.2013–31.12.2013 | 21.05.2014 | ...... |
| 2012 | 01.01.2012–31.12.2012 | 09.05.2013 | ...... |
| 2011 | 01.01.2011–31.12.2011 | 10.05.2012 | ...... |
| 2010 | 01.01.2010–31.12.2010 | 08.06.2011 | ...... |
| 2009 | 01.01.2009–31.12.2009 | 27.05.2010 | ...... |
| 2008 | 01.01.2008–31.12.2008 | 30.06.2009 | ...... |
| 2007 | 01.01.2007–31.12.2007 | 09.06.2008 | ...... |
| 2006 | 01.01.2006–31.12.2006 | 18.06.2007 | ...... |
Liabilities and debts
TBD PHARMATECH OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral
Borderline
Problematic
Risky
TBD PHARMATECH OÜ
Reports and assets-liabilities overview 06.05.2025?
Annual reports:
......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
TBD PHARMATECH OÜ
Claims history?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
TBD PHARMATECH OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2025 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 I | * ...... € | ...... € | ...... € | ...... € | ...... |
TBD PHARMATECH OÜ
Bailiff's enforcement proceedings as of 06.05.2025?
Bailiff's enforcement proceedings MISSING
TBD PHARMATECH OÜ
Regulations of the Payment Order Department as of 06.05.2025?
Regulations of the Payment Order Department MISSING
TBD PHARMATECH OÜ
Court orders in the register as of 06.05.2025?
Puuduste kõrvaldamise määrus
09.01.2023
Regulation number: Ä 20034659 / M7
Regulation status has entered into force: 12.01.2023
Date of enforcement of order or additional period: 09.01.2023
Regulation status: Puudused kõrvaldatud
TBD PHARMATECH OÜ
Decisions of the Consumer Disputes Committee as of 06.05.2025?
Consumer disputes MISSING
TBD PHARMATECH OÜ
Court hearings as of 06.05.2025?
Court hearings MISSING
TBD PHARMATECH OÜ
Rulings as of 06.05.2025?
Court settlemets MISSING
TBD PHARMATECH OÜ
Notices and announcements as of 06.05.2025?
Notice of granting or refusing to grant an integrated permit
24.04.2025
Kompleksloa andmise või andmisest keeldumise teade
Avaldamise algus: 24.04.2025
Avaldamise lõpp: 25.04.2125
Avaldamise lõpp: 25.04.2125
Keskkonnaamet avaldab teadaande keskkonnaseadustiku üldosa seaduse (KeÜS) § 58 lõike 3 alusel.
Keskkonnaamet teatab, et osaühing TBD Pharmatech (registrikood: 11204964) (aadress Tiigi tn 61b, Tartu linn, Tartu linn, Tartu maakond, 50410) 26.08.2024 esitatud nõuetekohase taotluse alusel andis 24.04.2025 tähtajatu kehtivusega keskkonnakompleksloa nr KKL-522721.
Keskkonnakompleksluba reguleerib farmaatsiatoodete, sealhulgas nende vahesaaduste tootmist. Käitise territoorium asub Välja tn 4a, Soinaste küla, Kambja vald, Tartu maakond kinnistul (katastritunnus 94901:006:0031) ja selle ülesseatud tootmisvõimsuseks 5 tonni toodangut aastas.
Haldusakti ja muude asjasse puutuvate dokumentidega on võimalik tutvuda Keskkonnaameti kontorites üle Eesti.
Digitaalselt on dokumendid kättesaadavad keskkonnaotsuste infosüsteemis https://kotkas.envir.ee/menetlus/M-129022.
Keskkonnaamet teatab, et osaühing TBD Pharmatech (registrikood: 11204964) (aadress Tiigi tn 61b, Tartu linn, Tartu linn, Tartu maakond, 50410) 26.08.2024 esitatud nõuetekohase taotluse alusel andis 24.04.2025 tähtajatu kehtivusega keskkonnakompleksloa nr KKL-522721.
Keskkonnakompleksluba reguleerib farmaatsiatoodete, sealhulgas nende vahesaaduste tootmist. Käitise territoorium asub Välja tn 4a, Soinaste küla, Kambja vald, Tartu maakond kinnistul (katastritunnus 94901:006:0031) ja selle ülesseatud tootmisvõimsuseks 5 tonni toodangut aastas.
Haldusakti ja muude asjasse puutuvate dokumentidega on võimalik tutvuda Keskkonnaameti kontorites üle Eesti.
Digitaalselt on dokumendid kättesaadavad keskkonnaotsuste infosüsteemis https://kotkas.envir.ee/menetlus/M-129022.
Keskkonnaamet
Pärnu linn, Pärnu linn, Pärnu maakond, Roheline tn 64
Telefon: +372 6625999
E-post: INFO@KESKKONNAAMET.EE
Pärnu linn, Pärnu linn, Pärnu maakond, Roheline tn 64
Telefon: +372 6625999
E-post: INFO@KESKKONNAAMET.EE
Teadaande number 2446776
Notice of publication of a draft integrated permit
07.04.2025
Kompleksloa eelnõu avalikustamise teade
Avaldamise algus: 07.04.2025
Avaldamise lõpp: 08.04.2125
Avaldamise lõpp: 08.04.2125
Keskkonnaamet avaldab teadaande keskkonnaseadustiku üldosa seaduse (KeÜS) § 47 lõike 2 alusel.
Keskkonnaamet teatab, et on valminud osaühing TBD Pharmatech (registrikood: 11204964) (aadress Tiigi tn 61b, Tartu linn, Tartu linn, Tartu maakond, 50410) keskkonnakompleksloa nr KKL-522721 andmise otsuse ja loa eelnõu ning taotletava tegevuse keskkonnamõjude eelhinnang.
Ettevõte taotleb tähtajatud keskkonnakompleksluba farmaatsiatoodete, sealhulgas nende vahesaaduste tootmiseks, mille ülesseatud tootmisvõimsuseks 5 tonni toodangut aastas. Taotletav tegevus toimub Välja tn 4a, Soinaste küla, Kambja vald, Tartu maakond kinnistul (katastritunnus 94901:006:0031).
Eelnõu(de) ja muude asjassepuutuvate dokumentidega on võimalik tutvuda Keskkonnaameti kontorites üle Eesti ja keskkonnaotsuste infosüsteemis.
Eelnõu on digitaalselt kättesaadav https://kotkas.envir.ee/menetlus/M-129022
Ettepanekuid ja vastuväiteid eelnõu(de)le saab esitada Keskkonnaametile suuliselt või e-posti aadressile info@keskonnaamet.ee või postiaadressile Roheline 64, 80010 Pärnu kahe nädala jooksul alates teate ilmumisest ametlikus väljaandes Ametlikud Teadaanded.
Keskkonnaamet teeb ettepaneku asja arutamiseks ilma avaliku istungit läbi viimata.
Keskkonnaamet teatab, et on valminud osaühing TBD Pharmatech (registrikood: 11204964) (aadress Tiigi tn 61b, Tartu linn, Tartu linn, Tartu maakond, 50410) keskkonnakompleksloa nr KKL-522721 andmise otsuse ja loa eelnõu ning taotletava tegevuse keskkonnamõjude eelhinnang.
Ettevõte taotleb tähtajatud keskkonnakompleksluba farmaatsiatoodete, sealhulgas nende vahesaaduste tootmiseks, mille ülesseatud tootmisvõimsuseks 5 tonni toodangut aastas. Taotletav tegevus toimub Välja tn 4a, Soinaste küla, Kambja vald, Tartu maakond kinnistul (katastritunnus 94901:006:0031).
Eelnõu(de) ja muude asjassepuutuvate dokumentidega on võimalik tutvuda Keskkonnaameti kontorites üle Eesti ja keskkonnaotsuste infosüsteemis.
Eelnõu on digitaalselt kättesaadav https://kotkas.envir.ee/menetlus/M-129022
Ettepanekuid ja vastuväiteid eelnõu(de)le saab esitada Keskkonnaametile suuliselt või e-posti aadressile info@keskonnaamet.ee või postiaadressile Roheline 64, 80010 Pärnu kahe nädala jooksul alates teate ilmumisest ametlikus väljaandes Ametlikud Teadaanded.
Keskkonnaamet teeb ettepaneku asja arutamiseks ilma avaliku istungit läbi viimata.
Keskkonnaamet
Pärnu linn, Pärnu linn, Pärnu maakond, Roheline tn 64
Telefon: +372 6625999
E-post: INFO@KESKKONNAAMET.EE
Pärnu linn, Pärnu linn, Pärnu maakond, Roheline tn 64
Telefon: +372 6625999
E-post: INFO@KESKKONNAAMET.EE
Teadaande number 2440219
Notice of initiation of proceedings for an integrated permit
12.09.2024
Kompleksloa menetluse algatamise teade
Avaldamise algus: 12.09.2024
Avaldamise lõpp: 13.09.2124
Avaldamise lõpp: 13.09.2124
Keskkonnaamet avaldab teadaande keskkonnaseadustiku üldosa seaduse (KeÜS) § 47 lõike 2 alusel.
Keskkonnaamet teatab, et osaühing TBD Pharmatech (registrikood: 11204964) (aadress Tiigi tn 61b, Tartu linn, Tartu linn, Tartu maakond, 50410) 26.08.2024 esitatud keskkonnakompleksloa taotlus nr T-KL/1024921-2 on võetud menetlusse.
Käitise territoorium asub Välja tn 4a, Soinaste küla, Kambja vald, Tartu maakond kinnistul (katastritunnus 94901:006:0031).
Taotletakse keskkonnakompleksluba farmaatsiatoodete, sealhulgas nende vahesaaduste tootmiseks, mille ülesseatud tootmisvõimsuseks 5 tonni toodangut aastas.
Keskkonnakompleksloa taotlusega ja muude asjassepuutuvate dokumentidega on võimalik tutvuda keskkonnaotsuste infosüsteemis https://kotkas.envir.ee/menetlus/M-129022.
Taotlus on digitaalselt kättesaadav https://kotkas.envir.ee/dokument/DM-129022-3.
Kuni keskkonnakompleksloa andmise või andmisest keeldumise otsuse tegemiseni on igaühel õigus esitada Keskkonnaametile oma põhjendatud ettepanekuid ja vastuväiteid. Ettepanekuid ja vastuväiteid võib esitada suuliselt või kirjalikult e-posti aadressil info@keskkonnaamet.ee või postiaadressil Roheline 64, 80010 Pärnu.
Keskkonnaamet teatab, et osaühing TBD Pharmatech (registrikood: 11204964) (aadress Tiigi tn 61b, Tartu linn, Tartu linn, Tartu maakond, 50410) 26.08.2024 esitatud keskkonnakompleksloa taotlus nr T-KL/1024921-2 on võetud menetlusse.
Käitise territoorium asub Välja tn 4a, Soinaste küla, Kambja vald, Tartu maakond kinnistul (katastritunnus 94901:006:0031).
Taotletakse keskkonnakompleksluba farmaatsiatoodete, sealhulgas nende vahesaaduste tootmiseks, mille ülesseatud tootmisvõimsuseks 5 tonni toodangut aastas.
Keskkonnakompleksloa taotlusega ja muude asjassepuutuvate dokumentidega on võimalik tutvuda keskkonnaotsuste infosüsteemis https://kotkas.envir.ee/menetlus/M-129022.
Taotlus on digitaalselt kättesaadav https://kotkas.envir.ee/dokument/DM-129022-3.
Kuni keskkonnakompleksloa andmise või andmisest keeldumise otsuse tegemiseni on igaühel õigus esitada Keskkonnaametile oma põhjendatud ettepanekuid ja vastuväiteid. Ettepanekuid ja vastuväiteid võib esitada suuliselt või kirjalikult e-posti aadressil info@keskkonnaamet.ee või postiaadressil Roheline 64, 80010 Pärnu.
Keskkonnakompleksloa andmise või andmisest keeldumise otsuse eelnõu valmimisest teavitab Keskkonnaamet täiendavalt ametlikus väljaandes Ametlikud Teadaanded.
Keskkonnaamet
Pärnu linn, Pärnu linn, Pärnu maakond, Roheline tn 64
Telefon: +372 6625999
E-post: INFO@KESKKONNAAMET.EE
Pärnu linn, Pärnu linn, Pärnu maakond, Roheline tn 64
Telefon: +372 6625999
E-post: INFO@KESKKONNAAMET.EE
Teadaande number 2359543
Marketing
Business network
TBD PHARMATECH OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
TBD PHARMATECH OÜ
Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
25.04.2025
Official announcements
24.04.2025 the announcement was made: ("Kompleksloa andmise või andmisest keeldumise teade")
10.04.2025
Employment data update
0 employee(s) joined the organization first quarter of 2025, and the average salary was 2920 € per month, which is 25,05% (585 €) higher than the preceding quarter.
(The average salary for the last 4 quarters was 2498 €)
10.04.2025
Payment of labor taxes
289 193 € of labor taxes were paid for the first quarter of 2025, which is 28,49% (64 130 €) higher, than the preceding quarter.
(The average tax payment for the last 4 quarters was 245 812 €)
10.04.2025
Payment of national taxes
269 060 € of national taxes were paid for the first quarter of 2025, which is 0% (269 060 €) higher, than the preceding quarter.
(The average tax payment for the last 4 quarters was 140 521 €)
No monitoring events found.
Failed to load monitoring events.